The compounding pharmacy sector could play a more important role in increasing adherence to treatments for chronic diseases, by providing a niche solution to one of the key obstacles to adherence identified by the World Health Organisation (WHO).
In their report, ‘Adherence to Long-Term therapies – Evidence for Action’, the organisation claims that strategies to help patients stick to their long-term medical plan, “…may have a far greater impact on the health of the population than any improvement in specific medical treatments.”
The report goes on to outline five key barriers to treatment adherence:
WHO’s top two barriers, ‘social and economic factors’ and the ‘health care system’ are complex and far-reaching. Improving these factors will require systemic and cultural change along with considerable funds.
Barrier no. 4 however – disease therapies – is the area where the compounding pharmacy sector can make the most contribution, in a low- cost way, by providing viable and sometimes preferable solutions to the treatment options offered by drug manufacturers.
In this capacity, compounding pharmacies can help in three main ways:
WHO claims that in developed countries only 50 per cent of patients on long-term treatment plans for chronic illnesses actually stick to their plans, while the rate in developing countries is believed to be much lower.
For more information on how compounding can help your patient’s stick to the medical treatment plan contact National Custom Compounding on 1300 731 755 or drop a line to [email protected].